NEW YORK, NY / ACCESSWIRE / February 22, 2018 / U.S. markets spiked to session highs after minutes from the Fed's January meeting were released, but then dropped as yields for the 10-year Treasury note jumped to 2.95 percent. The Dow Jones Industrial Average touched a high of 25,267.99, before settling to close at 24,797.78, down 0.67 percent, while the S&P 500 Index hit a high of 2,747.75 before settling to close at 2,701.33, a decrease of 0.55 percent. The Nasdaq Composite Index touched a high of 7,338.64 in intraday trading before settling to close at 7,218.23, a decrease of 0.22 percent.

"Today's minutes didn't give us much of what we didn't already know: rates are going up this year, inflation is rising modestly, unemployment remains low, and wages are ticking up, albeit slightly," said Mike Loewengart, vice president of investment strategy at E-Trade, according to CNBC. "The economy does not feel overheated, it feels like it's continuing its positive momentum from last year. Should we see a string of inflation metrics that suggests otherwise, then the thesis changes."

RDI Initiates Coverage on:

AVEO Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=AVEO

Exelixis, Inc.
https://rdinvesting.com/news/?ticker=EXEL

AVEO Pharmaceuticals' stock moved 1.03% higher Wednesday, to close the day at $2.94. The stock recorded a trading volume of 1,313,101 shares, which was below its three months average volume of 1,631,521 shares. In the last year, AVEO Pharmaceuticals' shares have traded in a range of 0.50 - 4.24. The share price has gained 488.00% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.95 is below its 200-day moving average of $3.16. Shares of AVEO Pharmaceuticals have gained roughly 0.34 percent in the past month and are up 5.38 percent year-to-date.

Access RDI's AVEO Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AVEO

On Wednesday, shares of Exelixis recorded a trading volume of 1,887,584 shares, which was below the three months average volume of 2,595,280 shares. The stock ended the day 0.55% higher at 28.99. The share price has gained 60.79% from its 52-week low with a 52-week trading range of 18.03 - 32.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $29.76 is greater than its 200-day moving average of $27.42. Shares of Exelixis are trading at a Price to Earnings ratio of 59.16. Shares of Exelixis have gained roughly 3.54 percent in the past month and are down 4.64 percent year-to-date.

Access RDI's Exelixis, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EXEL

Our Actionable Research on AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) and Exelixis, Inc. (NASDAQ:EXEL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com